Silver Book Fact

New cancer treatments account for large percent of life expectancy gains

Fact image

Sun E, Lakdawall D, Ryes C, Goldman D, et al. The Determinants of Recent Gains in Cancer Survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database. J Clin Oncolo. 2008; 27(15S). http://ascopubs.org/doi/abs/10.1200/jco.2008.26.15_suppl.6616

Reference

Title
The Determinants of Recent Gains in Cancer Survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
Publication
J Clin Oncolo
Publication Date
2008
Authors
Sun E, Lakdawall D, Ryes C, Goldman D, et al
Volume & Issue
Volume 27, Issue 15S
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.  
  • Decline in Cancer Death Rates in Men
     
  • Since 1980, 83 percent of gains in life expectancy for cancer patients have been attributable to new treatments.  
  • The standard treatment for prostate cancer used to require radical prostatectomy. Now, less invasive therapies like brachytherapy have been shown to have equal outcomes with fewer side effects.  
  • The 1-year survival rate for lung cancer has increased from 37% in 1975 to 42% in 1999-2001, largely because of improvements to surgical techniques and with combined therapies.